JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Whitepaper
Base editing and stem-cell based therapies
For years iPSCs have been the subject of intense research efforts with recent advances with gene editing technologies. Discover how base editing is pushing this further in the fields of basic science, regenerative medicine and immunotherapy.
In this white paper, you will learn about…
- An overview of induced pluripotent stem cells (iPSCs)
- How gene editing has been applied to iPSCs
How base editing can help to unlock the full potential of iPSCs for immunotherapies
The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.
To view the full content please answer a few questions
Download Resource
Base editing and stem-cell based therapies